In Vivo Activity Profiling of Biosynthetic Darobactin D22 against Critical Gram-Negative Pathogens.
Kany AM, Fries F, Seyfert CE, Porten C, Deckarm S, Chacón Ortiz M, Dubarry N, Vaddi S, Große M, Bernecker S, Sandargo B, Müller AV, Bacqué E, Stadler M, Herrmann J, Müller R.
Kany AM, et al. Among authors: muller av.
ACS Infect Dis. 2024 Dec 13;10(12):4337-4346. doi: 10.1021/acsinfecdis.4c00687. Epub 2024 Nov 20.
ACS Infect Dis. 2024.
PMID: 39565008
Free PMC article.